Synthesis and pharmacological evaluation of 1,1,3-substituted urea derivatives as potent TNF-alpha production inhibitors

Bioorg Med Chem Lett. 2010 Aug 1;20(15):4479-82. doi: 10.1016/j.bmcl.2010.06.037. Epub 2010 Jun 10.

Abstract

A three substituted urea derivative, SA13353 (compound 1a), exhibited potent inhibitory activity against lipopolysaccharide (LPS)-induced TNF-alpha production. We focused on the 1,1-substituted moiety (R(1) and R(2)) of SA13353 and investigated substituent effects of this moiety on LPS-induced TNF-alpha production by oral administration in rats. The synthesis of the urea derivatives was performed rapidly in a one-pot manner using a manual synthesizer. Several compounds containing hydrophobic substituents at this moiety showed more potent inhibitory activities than SA13353.

MeSH terms

  • Administration, Oral
  • Animals
  • Pyridines / pharmacology
  • Rats
  • Sulfenic Acids / chemistry
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Urea / analogs & derivatives*
  • Urea / chemical synthesis
  • Urea / pharmacology

Substances

  • 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea
  • Pyridines
  • Sulfenic Acids
  • Tumor Necrosis Factor-alpha
  • 2,4-dinitrobenzenesulfenamide
  • Urea